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Mitochondrial cytochrome oxidase is competitively and reversibly inhibited by inhibitors that bind to ferrous heme, such as carbon
monoxide and nitric oxide. In the case of nitric oxide, nanomolar levels inhibit cytochrome oxidase by competing with oxygen at the
enzyme’s heme–copper active site. This raises the Km for cellular respiration into the physiological range. This effect is readily reversible and
may be a physiological control mechanism. Here we show that a number of in vitro and in vivo conditions result in an irreversible increase in
the oxygen Km. These include: treatment of the purified enzyme with peroxynitrite or high (AM) levels of nitric oxide; treatment of the
endothelial-derived cell line, b.End5, with NO; activation of astrocytes by cytokines; reperfusion injury in the gerbil brain. Studies of cell
respiration that fail to vary the oxygen concentration systematically are therefore likely to significantly underestimate the degree of
irreversible damage to cytochrome oxidase.
D 2003 Elsevier B.V. All rights reserved.Keywords: Cytochrome c oxidase; Nitric oxide; Mitochondria; Km; Oxygen; Peroxynitrite1. Introduction
Mitochondrial cytochrome oxidase catalyses over 95% of
oxygen consumption by the eukaryotic cell [1]. Nitric oxide
(NO) is an intercellular signaling molecule that controls
many physiological processes in the body [2]. Nanomolar
levels of NO inhibit cytochrome oxidase by competing with
oxygen at the enzyme’s heme–copper active site [3,4]. This
raises the Km for oxygen of cellular respiration into the
physiological range of oxygen tension [5]. This effect is
readily reversible and may be a physiological control
mechanism in cells [6]. Relief of enzyme inhibition is0005-2728/$ - see front matter D 2003 Elsevier B.V. All rights reserved.
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Sciences, John Radcliffe Hospital, Oxford, Oxon OX3 9D, UK.characterised by conversion of the NO into nitrite [7]; this
nitrite formation may be one of the major means of
removing NO from inside cells, in order to turn off its
signaling effects or reduce its toxicity [8]. The biochemical
[9] and cellular physiological [10] consequences of the
effect of NO inhibition of cytochrome oxidases have re-
cently been reviewed.
Although persistent long-term, inhibitory effects are seen
on other mitochondrial enzymes (e.g. complex I, NADH
dehydrogenase, Ref. [11]), it has generally been assumed
that when the NO is removed from the solution, cyto-
chrome oxidase enzyme activity completely returns to
normal. However, overproduction of NO in many patho-
physiological conditions is associated with production of
peroxynitrite, the product of the reaction of NO with
superoxide [12]. We recently showed that peroxynitrite
irreversibly inhibits the turnover of purified cytochrome
oxidase, an effect largely mediated via an increase in the
Km for oxygen [13,14]. These effects are only detectable in
a high-resolution respirometer where the low Km’s for
oxygen of this enzyme can readily be measured [15] and
are therefore not detectable in studies where the oxygen
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found in the tissue in vivo [16].
We therefore studied a number of conditions in vitro and
in vivo where there is an increase in the concentration of
reactive nitrogen species. We found in these cases that there
was an increase in the oxygen Km, not attributable to the
presence of residual NO in the solution. Both NO or
peroxynitrite could initiate these long-term irreversible
effects.2. Materials and methods
2.1. Pure enzyme studies
Bovine heart mitochondrial cytochrome c oxidase was
purified as described previously [13]. For the purified
enzymes, the oxygen Km was determined using a high-
resolution OroborosR respirometer—for a full explanation
of the technique see Ref. [15]. Briefly, this oxygen
electrode system has a very low back-diffusion rate for
oxygen even at low oxygen tensions. This allows meas-
urements to be made at low rates of oxygen consumption
so that a significant number of data points can be
collected over the low oxygen tension (micromolar and
submicromolar) where the cytochrome oxidase Km lies.
Software corrections are applied for the response time of
the electrode and the autoxidation rate (rate of oxygen
consumption in the absence of enzyme). The latter is also
oxygen concentration-dependent, and the linear oxygen
concentration dependence of this rate was used to correct
the data over the full range of oxygen concentrations. The
corrected data were then fit to a hyperbolic curve to
determine Vmax and Km using non-linear least squares
regression.
2.2. Cell and mitochondrial studies
The cell and solubilized mitochondrial Km’s were mea-
sured using an in-house fabricated version of the Oroboros
system. The respirometer was a 1.5 ml thermostated glass
oxygen electrode chamber with a MicorR stopper to reduce
back-diffusion of oxygen. Again, the rate was corrected at
all oxygen tensions by subtraction of the background
oxygen consumption rate (a combination of back-diffusion
and consumption of oxygen by the electrode). Brain-endo-
thelial derived cell line b.End5 (0.65 ml, prepared as in Ref.
[17]), was added to a respirometer at a protein concentration
of 4.5 mg/ml. The buffer was 134.2 mM NaCl, 20 mM
glucose, 20 mM HEPES, 5.3 mM KCl, 4.1 mM NaHCO3,
2mM CaCl2, 0.43 mM KH2PO4, 0.33 mM Na2HPO4, pH
7.4, 30 jC. The solution was allowed to go anaerobic via
respiration on endogenous substrates. A saturated solution
of NO (measured at 2 mM) was then pumped in at a rate of
80 nmol of NO per ml buffer per hour (using a World
Precision Instruments UltraMicroPump). The measuredsteady state extracellular NO concentration under these
conditions was 6.1F 0.3 AM. After 1 h, the pump was
turned off and 14 AM of the NO scavenger 2-phenyl-
4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide (PTIO)
added to remove the remaining NO. The stopper was then
removed from the chamber and the solution stirred to raise
the oxygen concentration to f 200 AM. At this point, no
free NO remained in the solution as judged by an NO
electrode. The stopper was replaced and the oxygen con-
sumption rate measured.
Primary cultures of astrocytes were activated by cyto-
kines as described previously for 24 h [18]. The steady state
NO concentration following this activation has been mea-
sured at 1.15 AM [19]. The cells were then freeze–thawed
three times to break them and placed in the detergent lauryl
maltoside to solubilize them. Under these conditions, NO is
no longer produced by the cellular homogenate; the con-
centrations of the NO synthase substrates, arginine and
NADPH decrease dramatically and free NO drops to unde-
tectable levels.
2.3. Gerbil brain mitochondrial studies
Non-synaptic gerbil brain mitochondria were isolated
from the forebrain. Post-ischemic mitochondria were har-
vested from gerbils subjected to 30 min of ischemia (via
bilateral carotid artery occlusion) followed by a 2-h reperfu-
sion period. Sham-operated controls were identically treated
apart from the lack of ischemia. For full experimental details
of the protocol, see Canevari et al. [20]. The mitochondria
were suspended in a respirometer in 100 mM potassium
phosphate, 0.015% lauryl maltoside, 20 AM diethylenetria-
minepentaacetic acid (DTPA), pH 7.0, 30 jC. Oxygen
consumption by cytochrome oxidase was initiated by the
addition of 45 AM cytochrome c, 300 AM N,N,NV,NV-tetra-
methyl-p-phenylenediamine hydrochloride (TMPD) and 20
mM ascorbate.
2.4. Curve fitting
Non-linear regression was used to determine the Vmax
and Km, fitting plots of v vs. S to the simple Michaelis–
Menten mechanism. In the case of the isolated enzyme,
these values reflect the kcat and Km for cytochrome oxidase.
In the case of whole cell oxygen consumption (Fig. 3), the
term oxygen p50 is perhaps more appropriate [20], rather
than Km as factors external to cytochrome oxidase could
affect this number. To aid comparisons between studies, all
the data were analysed over the same substrate fit range (0–
20 AM oxygen).
2.5. Statistics
Unless otherwise indicated, all errors are quotedF 1 S.D.
Standard t-tests (paired when appropriate) were used to test
for significance between control and treated samples.
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Purified, solubilized, mitochondrial cytochrome oxidase
was incubated with saturating concentrations of ferrocyto-
chrome c. When the oxygen concentration in the reaction
vessel reached 130 AM, micromolar levels of NO were
added. Complete inhibition was observed due to the directFig. 1. Method for measuring irreversible effects of nitrogen oxides on
cytochrome c oxidase kinetic parameters. (a) Cytochrome oxidase (5 nM),
in 100 mM K+ phosphate, pH 7.0, 0.1% lauryl maltoside, 100 nM catalase,
75 units superoxide dismutase, 37 jC, was incubated with 45 AM
cytochrome c, 300 AM TMPD and 20 mM sodium ascorbate. When the
oxygen tension was reduced to 50% of the air-saturated value, NO (10 AM)
was added to the solution. NO was removed from the solution by the
addition of 100 AM hemoglobin (Hb). Following anaerobiosis, hydrogen
peroxide additions were made (450 AM) to inject oxygen into the
respirometer. (b) The data in the low oxygen regime (indicated by the
box in (a)) were re-plotted as [O2] vs. rate of oxygen consumption (here
illustrated as electron flow through each enzyme molecule per second),
allowing Vmax and Km to be measured by fitting rectangular hyperbolae.
Fig. 2. Irreversible effects of NO on cytochrome oxidase Km for oxygen.
Data obtained from experiments as in Fig. 1, following the addition of
different concentrations of NO.effects of NO. As the NO was removed from the solution,
the enzyme activity increased. However, the activity did
not return to the 100% uninhibited rate; this effect was
exaggerated at low oxygen tensions ( < 20 AM), suggesting
an irreversible effect on the oxygen Km for cytochrome
oxidase.
We therefore performed a systematic study on these
irreversible effects of NO on the kinetic parameters of
purified cytochrome oxidase. The typical experimental
design for these studies is illustrated in Fig. 1. Cyto-
chrome oxidase was incubated with saturating concentra-
tions of ferrocytochrome in an oxygen electrode. At 130
AM oxygen, varying concentrations of NO were added.
Hemoglobin was routinely added subsequently to scav-
enge the NO, although essentially the same effects were
used in its absence (so long as enough time had expired so
that the NO concentration was reduced to undetectable
levels, as judged by separate nitric oxide electrode stud-
ies). Catalase and superoxide dismutase were present in
the studies described, but there was no noticeable effect if
they were omitted. Repeated measurements could be made
by re-introducing oxygen via peroxide addition (in the
presence of catalase). The data in the low oxygen region
(as indicated by the box) were re-plotted as v vs. [O2]
plots and analysed for oxygen Km as described in Materi-
als and methods (Fig. 1b). An increased Km following NO
addition could clearly be seen. The concentration depen-
dence of the NO effect is shown in Fig. 2. NO concen-
trations lower than 1 AM have negligible effect, but there
is already a tripling of Km by 3 AM.
We confirmed that the raised Km results from a
permanent effect on the enzyme or its immediate envi-
ronment by measuring the Km following a number of
Fig. 3. Irreversible effects of NO on cytochrome oxidase Km for oxygen.
Data obtained from experiments as in Fig. 1 using 10 AMNO. Comparisons
made between analysis of the Km on the first, second, third or fourth
deoxygenation cycle. No significant differences were observed.
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increase is permanent and time-independent (i.e. the
damage occurs immediately following the NO addition,
and not subsequently).
The pattern of irreversible inhibition described here for
NO is similar to that we have described previously for
ONOO [13]. At low concentrations (0–3 AM NO and 0–
20 AM ONOO), the two nitrogen oxides have identical
irreversible effects on the Vmax/Km ratio, suggesting similar
molecular target sites on the enzyme (Fig. 4). At higher
concentrations, the effects diverge, and ONOO has moreFig. 4. Comparison of the irreversible effects of low concentrations of NO
and peroxynitrite on the cytochrome oxidase kinetic parameters. Conditions
the same as in Fig. 1. NO (o) concentration range used, 0–3 AM; ONOO
(.) concentration range used, 0–20 AM.effect on Vmax than NO, for a given increase in the Km
(Fig. 5). This additional damage is likely due to the ability
of ONOO to degrade the heme and copper prosthetic
groups in the enzyme at these higher concentrations [13],
and is consistent in general with the more damaging
effects of ONOO on metalloproteins, when compared
to NO [21].
If the nitrogen oxide effects on cytochrome oxidase are
irreversible, they should still be observed in cells and in
vivo long after the removal of the nitrosative stress. To
check this we studied a number of systems undergoing
nitrosative stress. It is also possible to observe irreversible
increases in the oxygen Km (p50) in intact cells. In Fig. 6, it
can be seen that treatment of an endothelial-derived cell line
(b.End5) with low levels of NO for 1 h can permanently
raise the p50 for oxygen. Therefore, irreversible increases in
the cellular oxygen Km (p50) can be detected following the
addition of reactive nitrogen species. It is also possible toFig. 5. Comparison of the irreversible effects of high concentrations of NO
and peroxynitrite on the cytochrome oxidase kinetic parameters. Multiple
experiments (n= 8) carried out as in Fig. 1 at the indicated concentrations of
NO and ONOO. Effects on Vmax (a) and oxygen Km (b). Data plotted as
meansF S.D. All data were significantly different from each other
( P < 0.05 or smaller).
Fig. 6. Irreversible increases in cellular Km (p50) for oxygen. Experimental
details as described in Materials and methods. In b.end5 cells, the Km (p50)
increased from 0.84F 0.34 to 6.22F 3.08 AM (n = 19, P < 0.001).
Following astrocyte activation, the cytochrome oxidase Km for oxygen
increased from 0.97F 0.39 to 2.17F 0.69 AM (n= 6, P< 0.01).
C.E. Cooper et al. / Biochimica et Biophysica Acta 1607 (2003) 27–34 31observe these effects when NO is produced endogenously,
rather than added by the experimenter. In a previous study, it
was shown that the NO produced from the activation of NO
synthase by cytokine treatment can competitively inhibit
cytochrome oxidase in primary astrocyte cultures [22]. We
therefore took astrocytes pre-treated with cytokines for 24Fig. 7. Irreversible increases in cytochrome oxidase Km for oxygen in gerbil brai
Materials and methods. Values from Michaelis–Menten fit to data (F S.E. from th
protein 1; Km= 1.89F 0.04 AM; post-ischemic (D): Vmax = 266F 5 nmol O minh and solubilized them (a treatment which immediately
abolishes significant NO production in the homogenate).
The cytochrome oxidase oxygen Km was then assayed as
described in Fig. 1. We detected a small, but significant,
long-term irreversible rise in the cytochrome oxidase Km
when compared to control cells (Fig. 6), consistent with the
effects of NO or ONOO outlined above. The observed Km
increase could not be due to residual low levels of NO
production as the addition of the NO scavenger PTIO after
solubilization (but before the assay) had no effect on the
subsequent Km measurements.
Irreversible increases in the cytochrome oxidase oxygen
Km can also be observed in mitochondria prepared from
animal models of reperfusion injury. Fig. 7 shows that
following ischemia-reperfusion injury to the gerbil brain,
the Vmax and Km for cytochrome oxidase are both perturbed.
There is an almost 300% increase in the Km with a 50%
decrease in the Vmax. This model of reperfusion injury is
known to generate nitrosative stress. Whilst we cannot be
sure that this is the cause of the observed effect, clearly
damage of the same type observed in cytochrome oxidase in
vitro can also occur in vivo.4. Discussion
We have shown that NO can irreversibly raise the oxygen
Km of purified cytochrome oxidase, when directly measured
using artificial electron donors and exogenous cytochrome c.n mitochondria following hypoxia-ischemia. Data collected as described in
e non-linear regression fit). Control (o): Vmax = 563F 3 nmol O min
 1 mg
 1 mg protein 1; Km= 5.27F 0.10 AM.
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previously reported for peroxynitrite [13], but occurs at
lower concentrations. One plausible mechanism for the
stronger effect of NO would be if it reacted with an oxygen
intermediate to generate a locally high concentration of
peroxynitrite in the binuclear center. In this context, it is
intriguing that the decomposition of the ferrous-oxy complex
of hemoglobin by NO has been purported to occur via a
peroxynitrite intermediate [23]. Although, we cannot rule out
a direct effect of the N2O3 or NO2, formed during the aerobic
breakdown of micromolar NO, the trace concentrations these
species reach in the steady state make this unlikely [24].
We have also shown that similar irreversible effects are
seen in the p50 for cellular respiration, following prolonged
exposure to NO. These findings are likely to have patho-
physiological consequences. Nitric oxide and peroxynitrite
have both been implicated in the mitochondrial control of
apoptotic cell death [25,26] and in a wide variety of
pathophysiologies [27]. However, the assays of the effect
of these nitrogen oxides on mitochondrial electron transfer
in vitro are invariably carried out at unphysiologically high
oxygen concentrations where the effects seen in this paper
would be completely missed [16,28,29]. Previously it had
been thought that the Km for oxygen of cellular respiration
was only affected indirectly, either via the rate of electron
entry to cytochrome oxidase from cytochrome c or via
effects of the mitochondrial proton motive force on internal
electron transfer events in the enzyme [30]. It is now clear
that direct effects on cytochrome oxidase can reversibly and
irreversibly raise the Km for oxygen. Thus at levels below 1
AM NO, there is very little, if any, irreversible effects of NO
on cytochrome oxidase turnover. This is important as it
means that physiological levels of NO are unlikely to
irreversibly damage the enzyme. However, the effects
observed in Fig. 1 are well within the pathophysiological
range of NO concentrations as observed in, for example,
septic shock [31] or following hypoxia-ischemia [32].
The increased oxygen Km observed in the purified
enzyme is repeated in the cell studies, whether NO is added
exogenously, or produced endogenously by activation of
NO synthase activity. However, in the cellular studies we
cannot control or measure the intracellular NO and perox-
ynitrite concentrations; therefore we cannot be sure that the
increase in Km is due to the direct NO effects described in
Fig. 1. Other factors may come into play. For example
ONOO formation from NO [13] would also raise the
oxygen Km. Nevertheless, whatever the precise mechanism,
it is clear that long-term irreversible effects on cytochrome
oxidase can influence cellular respiration and bring the
oxygen p50 to levels where there is likely to be a significant
perturbation of energy metabolism. In the case of nitric
oxide, a reversible effect at nM NO concentrations becomes
an irreversible effect at AM levels. Thus reversible inhibition
during physiology would become irreversible damage dur-
ing pathophysiology. The studies on the gerbil brain mito-
chondria demonstrate that this is a very real possibility.Mitochondria purified from gerbil brains following reperfu-
sion injury have cytochrome oxidase molecules with in-
creased oxygen Km’s. The decrease in the Vmax described
here suggests that other factors may be also at play here;
these could include, for example, the removal of the metal
centers of the enzyme which occurs at high ONOO
concentrations [13].
What is the mechanism of NO action? We have previ-
ously shown that NO can react with ferrocytochrome c to
form the nitroxyl anion (NO), which can subsequently
react with oxygen to form ONOO [33]. However, even if
all the NO was converted to peroxynitrite by this mecha-
nism the effect would be minimal; 3 AM NO would have to
be converted to over 30 AM ONOO in solution to have the
same effect on Vmax/Km. Neither of the stable oxidation
products of NO metabolism, nitrite and nitrate had signif-
icant effects on cytochrome oxidase turnover. We were
unable to inhibit the enzyme with nitrate at any concentra-
tion, and the Ki for nitrite inhibition is in the mM concen-
tration range (results not shown).
Although NO interacts with the oxidised CuB in the
active site [34], under the conditions of the experiments on
the purified enzyme described here (fast electron flux at
high concentrations of reductants), NO will be primarily
interacting with the ferrous heme a3 site on the enzyme [35].
However, in the cell studies (low to medium electron flux),
it is likely that NO is interacting with both CuB and heme a3.
Whatever the primary target on the enzyme, the fact that NO
and ONOO have similar effects at low concentration,
suggests that a nitration event is the most likely chemical
mechanism for the irreversible damage caused by NO.
Bovine heart cytochrome oxidase has 72 tyrosine residues
and 18 cysteine residues making a search for potential
nitration/nitrosation targets difficult. Even in the key cata-
lytic subunit I, there are seven conserved tyrosine residues
between the mammalian and bacterial (E. coli) enzymes,
likely to play an important role in enzyme function. A
number of groups using antibodies to nitrotyrosine, have
demonstrated nitration of tyrosine residues [16,36]. Pinning
down a specific residue to the functional effects observed
here is clearly a non-trivial task. However, we have per-
formed preliminary HPLC/MS data (results not shown)
demonstrating nitration of cytochrome oxidase under similar
conditions to those described in this paper, suggesting that it
may be possible to link structure to function in the future.
Intriguingly there are several possible mechanisms by which
protein modification could raise the Km for cytochrome
oxidase. It has been shown, for example, that reducing the
rate of electron transfer from the low spin heme to the
binuclear center [37], or mutating amino acid residue in this
‘‘oxygen channel’’ permanently increase the Km [38].
Although it is tempting to suggest specific amino acid
modifications in the oxidase by reactive nitrogen species,
the kinetic data presented here are not wholly consistent
with such a model. In the purified enzyme, the v vs. S plots
are good fits to single rectangular hyperbolae throughout
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trations. A very specific modification of an individual
amino acid should lead to two enzyme species, one with
a normal and one with a raised oxygen Km. This would
result in biphasic v vs. S plots, with a higher proportion of
the ‘‘raised Km’’ enzyme at higher inhibitor concentrations.
It is therefore possible there are multiple sites on the
enzyme (resulting in an apparent smooth increase in the
Km) or that the environment sensed by all of the enzyme
molecules is altered smoothly (e.g. by modification of the
lipid bilayer).
In this paper, we have demonstrated a new kind of
inhibition of cytochrome oxidase and mitochondrial func-
tion, both in vitro and in vivo. In contrast to the in vitro
studies, we cannot be sure of the agent responsible in the in
vivo studies. However, whatever the molecular mechanism
of the increased Km, these studies have implications for
assays of damage to mitochondrial enzymes. The vast
majority of these assays are carried out at unphysiologically
high oxygen concentrations [14]; conditions in vivo are
likely to be such that the increases in oxygen Km reported
here may be critical to cellular function. Therefore, studies
that describe in vitro and in vivo effects on cytochrome
oxidase activity need to measure the full range of kinetic
parameters (including the oxygen Km) to avoid a significant
underestimation of the damage occurring.Acknowledgements
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